Position in IQV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$222,203
-$37,018 QoQ
Shares Held
1,150
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#807
of 1,077 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026High Net Worth Advisory Group LLC holds $222,203 across 1 Diagnostics & Research name. IQV ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
This page
|
1,150 | $222,203 |
All Filings in IQV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,203 | 1,150 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $259,221 | 1,150 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $218,431 | 1,150 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $202,745 | 1,150 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $225,986 | 1,150 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $272,515 | 1,150 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $243,156 | 1,150 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $290,823 | 1,150 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $266,087 | 1,150 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $226,262 | 1,150 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $262,756 | 1,169 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $228,723 | 1,150 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $235,623 | 1,150 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $208,311 | 1,150 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $249,538 | 1,150 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $270,515 | 1,170 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $330,103 | 1,170 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||